Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy

Volume: 40, Issue: 1, Pages: 153 - 192
Published: Sep 25, 2018
Abstract
Diabetic neuropathy, with its major clinical sequels, notably neuropathic pain, foot ulcers, and autonomic dysfunction, is associated with substantial morbidity, increased risk of mortality, and reduced quality of life. Despite its major clinical impact, diabetic neuropathy remains underdiagnosed and undertreated. Moreover, the evidence supporting a benefit for causal treatment is weak at least in patients with type 2 diabetes, and current...
Paper Details
Title
Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
Published Date
Sep 25, 2018
Volume
40
Issue
1
Pages
153 - 192
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.